000290586 001__ 290586
000290586 005__ 20241105134656.0
000290586 0247_ $$2doi$$a10.3324/haematol.2023.284922
000290586 0247_ $$2pmid$$apmid:38813731
000290586 0247_ $$2ISSN$$a0390-6078
000290586 0247_ $$2ISSN$$a1592-8721
000290586 0247_ $$2altmetric$$aaltmetric:164134506
000290586 037__ $$aDKFZ-2024-01183
000290586 041__ $$aEnglish
000290586 082__ $$a610
000290586 1001_ $$aJaramillo, Sonia$$b0
000290586 245__ $$aLate-onset NPM1 mutation in a MYC-amplified relapsed / refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib.
000290586 260__ $$aPavia$$bFerrata Storti Foundation$$c2024
000290586 3367_ $$2DRIVER$$aarticle
000290586 3367_ $$2DataCite$$aOutput Types/Journal article
000290586 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1730810767_26818
000290586 3367_ $$2BibTeX$$aARTICLE
000290586 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000290586 3367_ $$00$$2EndNote$$aJournal Article
000290586 500__ $$a2024 Nov 1;109(11):3811-3815
000290586 520__ $$aNot available.
000290586 536__ $$0G:(DE-HGF)POF4-311$$a311 - Zellbiologie und Tumorbiologie (POF4-311)$$cPOF4-311$$fPOF IV$$x0
000290586 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000290586 7001_ $$aScherer, Michael$$b1
000290586 7001_ $$aSzu-Tu, Chelsea$$b2
000290586 7001_ $$aBeneyto-Calabuig, Sergi$$b3
000290586 7001_ $$aMüller-Tidow, Carsten$$b4
000290586 7001_ $$0P:(DE-He78)d8a0e60e5e095f3161ee0de3712409bc$$aSchlenk, Richard F$$b5$$udkfz
000290586 7001_ $$aHundemer, Michael$$b6
000290586 7001_ $$aVelten, Lars$$b7
000290586 7001_ $$aPabst, Caroline$$b8
000290586 773__ $$0PERI:(DE-600)2805244-4$$a10.3324/haematol.2023.284922$$n11$$p3811-3815$$tHaematologica$$v109$$x0390-6078$$y2024
000290586 909CO $$ooai:inrepo02.dkfz.de:290586$$pVDB
000290586 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d8a0e60e5e095f3161ee0de3712409bc$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000290586 9131_ $$0G:(DE-HGF)POF4-311$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vZellbiologie und Tumorbiologie$$x0
000290586 9141_ $$y2024
000290586 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-23
000290586 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-23
000290586 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-08-23
000290586 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-06-05T07:07:08Z
000290586 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-06-05T07:07:08Z
000290586 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Peer review$$d2023-06-05T07:07:08Z
000290586 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-23
000290586 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-08-23
000290586 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-08-23
000290586 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-23
000290586 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-08-23
000290586 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-08-23
000290586 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-08-23
000290586 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-08-23
000290586 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-08-23
000290586 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-08-23
000290586 9201_ $$0I:(DE-He78)W010-20160331$$kW010$$lKlinische Studienzentrale$$x0
000290586 980__ $$ajournal
000290586 980__ $$aVDB
000290586 980__ $$aI:(DE-He78)W010-20160331
000290586 980__ $$aUNRESTRICTED